AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
27 Feb 2009 10:00 AM
RNS
Board change
27 Feb 2009 07:00 AM
RNS
Seroquel XR CRL for GAD
26 Feb 2009 04:30 PM
RNS
Director/PDMR Shareholding
26 Feb 2009 04:30 PM
RNS
Director/PDMR Shareholding
26 Feb 2009 04:30 PM
RNS
Director/PDMR Shareholding
25 Feb 2009 04:30 PM
RNS
Director/PDMR Shareholding
25 Feb 2009 04:30 PM
RNS
Director/PDMR Shareholding
25 Feb 2009 01:00 PM
RNS
Seroquel XR
24 Feb 2009 07:00 AM
RNS
AstraZeneca and MAP: UDB
30 Jan 2009 04:00 PM
RNS
Total Voting Rights
29 Jan 2009 11:00 AM
RNS
Final Results - part 3 of 3
29 Jan 2009 11:00 AM
RNS
Final Results - part 2 of 3
29 Jan 2009 11:00 AM
RNS
AstraZeneca and Pozen : PN400
29 Jan 2009 11:00 AM
RNS
Currency Sensitivity Guide
29 Jan 2009 11:00 AM
RNS
Final Results - part 1 of 3
28 Jan 2009 09:00 AM
RNS
Notice of Results
22 Jan 2009 12:00 PM
RNS
Director/PDMR Shareholding
06 Jan 2009 08:00 AM
PRN
MedImmune Submits Marketing Authorisation Appli...
05 Jan 2009 04:00 PM
RNS
Total Voting Rights
24 Dec 2008 07:00 AM
RNS
Seroquel XR CRL
19 Dec 2008 12:38 PM
RNS
AstraZeneca and Map Pharmaceu
12 Dec 2008 07:00 AM
RNS
FDA AdCom on Symbicort
11 Dec 2008 11:00 AM
RNS
Return of Rights to Infinity
09 Dec 2008 07:00 AM
RNS
Topline phase IIb results for
08 Dec 2008 12:30 PM
RNS
AstraZeneca and BMS - Dapagli
03 Dec 2008 01:00 PM
RNS
PN 400 Phase III Studies
28 Nov 2008 04:00 PM
RNS
Total Voting Rights
28 Nov 2008 07:00 AM
RNS
MOTAVIZUMAB CRL
26 Nov 2008 07:00 AM
RNS
Pulmicort Respules US litigat
25 Nov 2008 07:00 AM
RNS
Update on Abraxis agreement
20 Nov 2008 07:00 AM
RNS
Pulmicort
19 Nov 2008 03:45 PM
RNS
Pulmicort
19 Nov 2008 07:00 AM
RNS
Pulmicort
19 Nov 2008 07:00 AM
RNS
Zactima
13 Nov 2008 07:00 AM
RNS
Regulatory Approval
10 Nov 2008 07:00 AM
RNS
Crestor JUPITER study results
04 Nov 2008 07:00 AM
RNS
Directorate Change
31 Oct 2008 04:00 PM
RNS
Total Voting Rights
30 Oct 2008 11:00 AM
RNS
3rd Quarter Results - Part 2
30 Oct 2008 11:00 AM
RNS
3rd Quarter Results - Part 1
29 Oct 2008 09:00 AM
RNS
Notice of Results
17 Oct 2008 11:00 AM
RNS
AstraZeneca and Pozen PN400
16 Oct 2008 02:00 PM
PRN
MedImmune Expands R&D Capacity with New Res...
02 Oct 2008 07:00 AM
RNS
Transaction in Own Shares
01 Oct 2008 07:00 AM
RNS
Transaction in Own Shares
30 Sep 2008 04:00 PM
RNS
Total Voting Rights
30 Sep 2008 12:00 PM
RNS
Transaction in Own Shares
30 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
29 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
26 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100

Latest directors dealings